{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T23:10:03Z","timestamp":1792883403849,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T00:00:00Z","timestamp":1531094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T00:00:00Z","timestamp":1531094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Fatty liver (FL) disease is the most common type of chronic liver disease. We hypothesized that liver\u2019s response to the process where large droplets of triglyceride fat accumulate in liver cells is reflected also in gene pathway expression in blood. Peripheral blood genome wide gene expression analysis and ultrasonic imaging of liver were performed for 1,650 participants (316 individuals with FL and 1,334 controls) of the Young Finns Study. Gene set enrichment analysis (GSEA) was performed for the expression data. Fourteen gene sets were upregulated (false discovery rate, FDR\u2009&lt;\u20090.05) in subjects with FL. These pathways related to extracellular matrix (ECM) turnover, immune response regulation, prothrombotic state and neural tissues. After adjustment for known risk factors and biomarkers of FL, we found i) integrin A4B1 signaling, ii) leukocyte transendothelial migration, iii) CD40\/CD40L and iv) netrin-1 signaling pathways to be upregulated in individuals with FL (nominal p\u2009&lt;\u20090.05). From these all but not ii) remained significantly upregulated when analyzing only subjects without history of heavy alcohol use. In conclusion, FL was associated with blood gene sets of ECM turnover, inflammatory response, immune system activation and prothrombotic state. These may form a systemic link between FL and the development of cardiovascular diseases.<\/jats:p>","DOI":"10.1038\/s41598-018-28563-y","type":"journal-article","created":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T14:20:45Z","timestamp":1530627645000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Fatty liver is associated with blood pathways of inflammatory response, immune system activation and prothrombotic state in Young Finns Study"],"prefix":"10.1038","volume":"8","author":[{"given":"Tuukka","family":"Taipale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5595-2573","authenticated-orcid":false,"given":"Ilkka","family":"Sepp\u00e4l\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Raitoharju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Mononen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7200-5455","authenticated-orcid":false,"given":"Leo-Pekka","family":"Lyytik\u00e4inen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Illig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Waldenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Juonala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Hutri-K\u00e4h\u00f6nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niku","family":"Oksala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"K\u00e4h\u00f6nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olli","family":"Raitakari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terho","family":"Lehtim\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,9]]},"reference":[{"key":"28563_CR1","doi-asserted-by":"publisher","first-page":"G852","DOI":"10.1152\/ajpgi.00521.2005","volume":"290","author":"JK Reddy","year":"2006","unstructured":"Reddy, J. K. & Rao, M. S. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G852\u20138 (2006).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"28563_CR2","doi-asserted-by":"publisher","first-page":"846","DOI":"10.4254\/wjh.v7.i6.846","volume":"7","author":"SM Abd El-Kader","year":"2015","unstructured":"Abd El-Kader, S. M. & El-Den Ashmawy, E. M. Non-alcoholic fatty liver disease: The diagnosis and management. World J. Hepatol. 7, 846\u2013858 (2015).","journal-title":"World J. Hepatol."},{"key":"28563_CR3","doi-asserted-by":"publisher","first-page":"237-2458","DOI":"10.1186\/1471-2458-10-237","volume":"10","author":"A Kotronen","year":"2010","unstructured":"Kotronen, A. et al. Non-alcoholic and alcoholic fatty liver disease - two diseases of affluence associated with the metabolic syndrome and type 2 diabetes: the FIN-D2D survey. BMC Public Health 10, 237-2458\u201310-237 (2010).","journal-title":"BMC Public Health"},{"key":"28563_CR4","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/j.1365-2036.2007.03246.x","volume":"25","author":"P Angulo","year":"2007","unstructured":"Angulo, P. GI epidemiology: nonalcoholic fatty liver disease. Aliment. Pharmacol. Ther. 25, 883\u2013889 (2007).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"28563_CR5","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1056\/NEJMra0912063","volume":"363","author":"G Targher","year":"2010","unstructured":"Targher, G., Day, C. P. & Bonora, E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N. Engl. J. Med. 363, 1341\u20131350 (2010).","journal-title":"N. Engl. J. Med."},{"key":"28563_CR6","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1056\/NEJMra011775","volume":"346","author":"P Angulo","year":"2002","unstructured":"Angulo, P. Nonalcoholic fatty liver disease. N. Engl. J. Med. 346, 1221\u20131231 (2002).","journal-title":"N. Engl. J. Med."},{"key":"28563_CR7","doi-asserted-by":"publisher","first-page":"12082","DOI":"10.3748\/wjg.v20.i34.12082","volume":"20","author":"K Hassan","year":"2014","unstructured":"Hassan, K., Bhalla, V., El Regal, M. E. & A-Kader, H. H. Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemic. World J. Gastroenterol. 20, 12082\u201312101 (2014).","journal-title":"World J. Gastroenterol."},{"key":"28563_CR8","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00281-009-0152-9","volume":"31","author":"L Valenti","year":"2009","unstructured":"Valenti, L., Fracanzani, A. L. & Fargion, S. The immunopathogenesis of alcoholic and nonalcoholic steatohepatitis: two triggers for one disease? Semin. Immunopathol. 31, 359\u2013369 (2009).","journal-title":"Semin. Immunopathol."},{"key":"28563_CR9","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/hep.27332","volume":"61","author":"E Seki","year":"2015","unstructured":"Seki, E. & Schwabe, R. F. Hepatic inflammation and fibrosis: functional links and key pathways. Hepatology 61, 1066\u20131079 (2015).","journal-title":"Hepatology"},{"key":"28563_CR10","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1007\/s10620-016-4049-x","volume":"61","author":"M Arrese","year":"2016","unstructured":"Arrese, M., Cabrera, D., Kalergis, A. M. & Feldstein, A. E. Innate Immunity and Inflammation in NAFLD\/NASH. Dig. Dis. Sci. 61, 1294\u20131303 (2016).","journal-title":"Dig. Dis. Sci."},{"key":"28563_CR11","doi-asserted-by":"publisher","first-page":"e58895","DOI":"10.1371\/journal.pone.0058895","volume":"8","author":"S Sookoian","year":"2013","unstructured":"Sookoian, S. & Pirola, C. J. Systems biology elucidates common pathogenic mechanisms between nonalcoholic and alcoholic-fatty liver disease. PLoS One 8, e58895 (2013).","journal-title":"PLoS One"},{"key":"28563_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.15280\/jlm.2015.5.1.7","volume":"5","author":"KB Bang","year":"2015","unstructured":"Bang, K. B. & Cho, Y. K. Comorbidities and Metabolic Derangement of NAFLD. J. Lifestyle Med. 5, 7\u201313 (2015).","journal-title":"J. Lifestyle Med."},{"key":"28563_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1586\/17474124.2016.1111758","volume":"10","author":"S Sutti","year":"2016","unstructured":"Sutti, S., Bruzzi, S. & Albano, E. The role of immune mechanisms in alcoholic and nonalcoholic steatohepatitis: a 2015 update. Expert Rev. Gastroenterol. Hepatol. 10, 243\u2013253 (2016).","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"28563_CR14","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1093\/ije\/dym225","volume":"37","author":"OT Raitakari","year":"2008","unstructured":"Raitakari, O. T. et al. Cohort profile: the cardiovascular risk in Young Finns Study. Int. J. Epidemiol. 37, 1220\u20131226 (2008).","journal-title":"Int. J. Epidemiol."},{"key":"28563_CR15","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KG Alberti","year":"2009","unstructured":"Alberti, K. G. et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120, 1640\u20131645 (2009).","journal-title":"Circulation"},{"key":"28563_CR16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.amepre.2004.12.003","volume":"28","author":"R Telama","year":"2005","unstructured":"Telama, R. et al. Physical activity from childhood to adulthood: a 21-year tracking study. Am. J. Prev. Med. 28, 267\u2013273 (2005).","journal-title":"Am. J. Prev. Med."},{"key":"28563_CR17","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1038\/oby.2009.154","volume":"17","author":"MA Edens","year":"2009","unstructured":"Edens, M. A. et al. Ultrasonography to quantify hepatic fat content: validation by 1H magnetic resonance spectroscopy. Obesity (Silver Spring) 17, 2239\u20132244 (2009).","journal-title":"Obesity (Silver Spring)"},{"key":"28563_CR18","doi-asserted-by":"crossref","unstructured":"Saverymuttu, S. H., Joseph, A. E. & Maxwell, J. D. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br. Med. J. (Clin. Res. Ed) 292, 13\u201315 (1986).","DOI":"10.1136\/bmj.292.6512.13"},{"key":"28563_CR19","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/hep.25762","volume":"55","author":"N Chalasani","year":"2012","unstructured":"Chalasani, N. et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55, 2005\u20132023 (2012).","journal-title":"Hepatology"},{"key":"28563_CR20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3109\/07853890.2014.966752","volume":"47","author":"E Suomela","year":"2015","unstructured":"Suomela, E. et al. Prevalence and determinants of fatty liver in normal-weight and overweight young adults. The Cardiovascular Risk in Young Finns Study. Ann. Med. 47, 40\u201346 (2015).","journal-title":"Ann. Med."},{"key":"28563_CR21","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon, A. et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics 27, 1739\u20131740 (2011).","journal-title":"Bioinformatics"},{"key":"28563_CR22","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"28563_CR23","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha, V. K. et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267\u2013273 (2003).","journal-title":"Nat. Genet."},{"key":"28563_CR24","doi-asserted-by":"publisher","first-page":"e50938","DOI":"10.1371\/journal.pone.0050938","volume":"7","author":"C Schurmann","year":"2012","unstructured":"Schurmann, C. et al. Analyzing illumina gene expression microarray data from different tissues: methodological aspects of data analysis in the metaxpress consortium. PLoS One 7, e50938 (2012).","journal-title":"PLoS One"},{"key":"28563_CR25","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jpsychires.2015.09.017","volume":"71","author":"M Elovainio","year":"2015","unstructured":"Elovainio, M. et al. Activated immune-inflammatory pathways are associated with long-standing depressive symptoms: Evidence from gene-set enrichment analyses in the Young Finns Study. J. Psychiatr. Res. 71, 120\u2013125 (2015).","journal-title":"J. Psychiatr. Res."},{"key":"28563_CR26","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1161\/CIRCGENETICS.113.000141","volume":"6","author":"N Oksala","year":"2013","unstructured":"Oksala, N. et al. Association of neuroimmune guidance cue netrin-1 and its chemorepulsive receptor UNC5B with atherosclerotic plaque expression signatures and stability in human(s): Tampere Vascular Study (TVS). Circ. Cardiovasc. Genet. 6, 579\u2013587 (2013).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"28563_CR27","doi-asserted-by":"publisher","first-page":"18307","DOI":"10.1074\/jbc.M700211200","volume":"282","author":"S Chakrabarti","year":"2007","unstructured":"Chakrabarti, S., Blair, P. & Freedman, J. E. CD40-40L signaling in vascular inflammation. J. Biol. Chem. 282, 18307\u201318317 (2007).","journal-title":"J. Biol. Chem."},{"key":"28563_CR28","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1007\/s10439-011-0461-8","volume":"40","author":"R Sackstein","year":"2012","unstructured":"Sackstein, R. Glycoengineering of HCELL, the human bone marrow homing receptor: sweetly programming cell migration. Ann. Biomed. Eng. 40, 766\u2013776 (2012).","journal-title":"Ann. Biomed. Eng."},{"key":"28563_CR29","doi-asserted-by":"publisher","first-page":"946509","DOI":"10.1155\/2015\/946509","volume":"2015","author":"M Schnoor","year":"2015","unstructured":"Schnoor, M., Alcaide, P., Voisin, M. B. & van Buul, J. D. Crossing the Vascular Wall: Common and Unique Mechanisms Exploited by Different Leukocyte Subsets during Extravasation. Mediators Inflamm. 2015, 946509 (2015).","journal-title":"Mediators Inflamm."},{"key":"28563_CR30","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1161\/01.ATV.0000122854.76267.5c","volume":"24","author":"JD van Buul","year":"2004","unstructured":"van Buul, J. D. & Hordijk, P. L. Signaling in leukocyte transendothelial migration. Arterioscler. Thromb. Vasc. Biol. 24, 824\u2013833 (2004).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"28563_CR31","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/hep.28347","volume":"63","author":"M Schlegel","year":"2016","unstructured":"Schlegel, M. et al. The neuroimmune guidance cue netrin-1 controls resolution programs and promotes liver regeneration. Hepatology 63, 1689\u20131705 (2016).","journal-title":"Hepatology"},{"key":"28563_CR32","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.ccell.2014.09.003","volume":"26","author":"MJ Wolf","year":"2014","unstructured":"Wolf, M. J. et al. Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes. Cancer. Cell. 26, 549\u2013564 (2014).","journal-title":"Cancer. Cell."},{"key":"28563_CR33","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.atherosclerosis.2009.10.011","volume":"209","author":"S Sookoian","year":"2010","unstructured":"Sookoian, S. et al. Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease. Atherosclerosis 209, 585\u2013591 (2010).","journal-title":"Atherosclerosis"},{"key":"28563_CR34","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1007\/s10620-009-0817-1","volume":"55","author":"CN Ercin","year":"2010","unstructured":"Ercin, C. N. et al. Levels of soluble CD40 ligand and P-Selectin in nonalcoholic fatty liver disease. Dig. Dis. Sci. 55, 1128\u20131134 (2010).","journal-title":"Dig. Dis. Sci."},{"key":"28563_CR35","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1161\/ATVBAHA.111.231357","volume":"31","author":"M Poggi","year":"2011","unstructured":"Poggi, M. et al. CD40L deficiency ameliorates adipose tissue inflammation and metabolic manifestations of obesity in mice. Arterioscler. Thromb. Vasc. Biol. 31, 2251\u20132260 (2011).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"28563_CR36","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.taap.2008.08.008","volume":"233","author":"A Banerjee","year":"2008","unstructured":"Banerjee, A., Lee, J. H. & Ramaiah, S. K. Interaction of osteopontin with neutrophil alpha(4)beta(1) and alpha(9)beta(1) integrins in a rodent model of alcoholic liver disease. Toxicol. Appl. Pharmacol. 233, 238\u2013246 (2008).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"28563_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-0-387-76715-4_2","volume":"621","author":"SW Moore","year":"2007","unstructured":"Moore, S. W., Tessier-Lavigne, M. & Kennedy, T. E. Netrins and their receptors. Adv. Exp. Med. Biol. 621, 17\u201331 (2007).","journal-title":"Adv. Exp. Med. Biol."},{"key":"28563_CR38","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.metabol.2014.09.001","volume":"63","author":"A Wree","year":"2014","unstructured":"Wree, A. et al. Adipocyte cell size, free fatty acids and apolipoproteins are associated with non-alcoholic liver injury progression in severely obese patients. Metabolism 63, 1542\u20131552 (2014).","journal-title":"Metabolism"},{"key":"28563_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/srep13058","volume":"5","author":"J Kalsch","year":"2015","unstructured":"Kalsch, J. et al. Normal liver enzymes are correlated with severity of metabolic syndrome in a large population based cohort. Sci. Rep. 5, 13058 (2015).","journal-title":"Sci. Rep."},{"key":"28563_CR40","doi-asserted-by":"publisher","first-page":"10363","DOI":"10.1074\/jbc.M116.717694","volume":"291","author":"L Lu","year":"2016","unstructured":"Lu, L. et al. Kindlin-3 Is Essential for the Resting alpha4beta1 Integrin-mediated Firm Cell Adhesion under Shear Flow Conditions. J. Biol. Chem. 291, 10363\u201310371 (2016).","journal-title":"J. Biol. Chem."},{"key":"28563_CR41","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.atherosclerosis.2015.06.058","volume":"242","author":"N Oksala","year":"2015","unstructured":"Oksala, N. et al. Kindlin 3 (FERMT3) is associated with unstable atherosclerotic plaques, anti-inflammatory type II macrophages and upregulation of beta-2 integrins in all major arterial beds. Atherosclerosis 242, 145\u2013154 (2015).","journal-title":"Atherosclerosis"},{"key":"28563_CR42","doi-asserted-by":"publisher","first-page":"e2807","DOI":"10.1097\/MD.0000000000002807","volume":"95","author":"T Baars","year":"2016","unstructured":"Baars, T. et al. In Acute Myocardial Infarction Liver Parameters Are Associated With Stenosis Diameter. Medicine (Baltimore) 95, e2807 (2016).","journal-title":"Medicine (Baltimore)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28563-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28563-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28563-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T07:10:22Z","timestamp":1671606622000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28563-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,9]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["28563"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-28563-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,9]]},"assertion":[{"value":"10 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"10358"}}